Daniel McGrath Elected Senior Director of the Federation of Defense & Corporate Counsel
Press Release | 1 min read
Aug 19, 2024
The law firm of Hinshaw & Culbertson LLP is pleased to announce that Chicago partner Daniel McGrath has been elected to serve as a Senior Director of the Federation of Defense & Corporate Counsel (FDCC) for the 2025–2026 term.
He was inducted alongside fellow officers and directors at the FDCC's Annual Meeting, which took place in Toronto from July 28 to August 3, 2024. He is also undertaking the role of Program Chair for the FDCC Winter Meeting in February 2025 in Charleston, South Carolina.
Founded in 1936, the FDCC is a professional trade association of peer-reviewed, premier defense and corporate counsel and industry executives. Membership is by invitation only. The FDCC aims to advance and sustain an equitable civil justice system through a community and network of trusted, leading, and innovative industry legal professionals.
McGrath has been an active member of the FDCC since 2003, holding several leadership positions, including Chair of the Local Meetings Project Committee (2017–2023), Illinois Membership Chair (2020– 2023), Co-Editor of the FDCC publication The Flyer, and as a Director of the FDCC from 2021–2024.
Related People
Related Capabilities
Related Locations
Featured Insights

Webinar
Oct 29, 2026
Carol Rooney Presents on Building a Career in Appellate Practice

In The News
Oct 28, 2026
James Ferrara Comments in The New York Times on Stalled Boca Raton Luxury Condo Project

Insights for Insurers Alert
Oct 28, 2026
Insurance and Reinsurance Commutations, Run-Off, and Loss Portfolio Transfers

Healthcare Alert
Oct 27, 2026
Illinois Medical Aid-in-Dying Law Takes Effect Amid Legal Challenges

In The News
Oct 26, 2026
Scott Seaman Examines the Insurance Coverage Implications of a Recent NFL Concussion Ruling

In The News
Oct 23, 2026
Michael Dowell Discusses Potential Impact of Proposition 44 on California Community Clinics

In The News
Oct 21, 2026
Scott Seaman Says Walmart Ruling is an "Aberration" in the Opioid Insurance Battle






